Greg Freiherr, Industry Consultant
Greg Freiherr, Industry Consultant

Greg Freiherr has reported on developments in radiology since 1983. He runs the consulting service, The Freiherr Group.

Blog | Greg Freiherr, Industry Consultant | RSNA 2017 | December 13, 2017 | Greg Freiherr

RSNA 2017: Often Real Systems (Were) Not Available

Siemens’ FAST (Fully Assisting Scanner Technologies) 3D Camera is designed to optimize patient positioning using artificial intelligence to evaluate optical and infrared pictures of the patient on the CT table below. #RSNA17, #RSNA2017

Hanging from the ceiling above a premium CT scanner, Siemens’ FAST (Fully Assisting Scanner Technologies) 3D Camera is designed to optimize patient positioning using artificial intelligence to evaluate optical and infrared pictures of the patient on the CT table below. Shown at RSNA 2017, the work in progress had not yet been cleared by the FDA for marketing in the U.S.

 

In the run-up to RSNA 1999, General Electric unveiled its 0.7T OpenSpeed. It was easy to be impressed. 

The conference was held amid the haunts of Saturday Night Live and NBC Network News. (At the time, GE owned NBC, as well as GE Medical Systems.)   It was hosted by GE Medical President and CEO Jeffrey Immelt (who would later become president and chairman of GE). And it featured the world’s first “high-field” open MR scanner.

What the other writers and I saw was not the real thing but an OpenSpeed mock-up. Three weeks later we saw it again (or one very similar to it), rotating on a stage in the center of the 2000-square-foot second floor (yes, “second” floor) of GE Medical’s booth at RSNA 1999.

GE was not the only exhibitor that knew how to put on a show. Vendors had become so skilled at smoke and mirrors that the abbreviation “RSNA” had come to mean (jokingly) “Real Systems Not Available.” 

The joke had been around for more than a decade (see “Real Systems Not Available: Punch Line or Prophecy?” , Imaging Technology News, Nov. 1, 2016). But after the launch of OpenSpeed, it reached new heights of comedy. 

Siemens Medical Systems (today Siemens Healthineers) had interpreted GE’s OpenSpeed news conference as an attempt to win over the radiology community with its prowess in MR. Not to be outdone, Siemens brought its own mock-up to the exhibit floor of RSNA 1999, one that promised a field strength beyond that of the OpenSpeed (1T versus 0.7T). But there was a problem. When I went to lean up against it, a member of the company’s PR staff stopped me. The mock-up, she said, was made of balsa wood. 

Siemens had been talking about a 1T open MR scanner for months. But GE’s “unveiling” of OpenSpeed lit a fire under the company to do more. In the three weeks between GE’s news conference and the opening of the RSNA exhibit floor, Siemens glued together a balsa mock-up of how the 1T was expected to look. 

In retrospect, imaging’s version of the Spruce Goose might have been a bit over the top. But mockups were what companies did back then. Competition was fierce. And the race to develop high-field open scanners was especially so. 

Just a few years earlier, the MR market was in free fall. Open MR sales had turned it around. Vendors did so with only low- and midfield units. High-field open MR was the next logical step. The companies working on it didn’t publicly address the technical hurdles. And we in the press were so shell shocked by the technology paraded before us each year that we didn’t question what was possible. MRI was itself astounding, as was multislice CT. And digital X-ray. And PET. And PACS. To put it simply, radiology was magical. 

A lot has changed since then. But the RSNA joke persists.

 

WIPs Today

At RSNA 2017, “works in progress” (WIPs) dotted the exhibit halls. Some were lightning rods for attention. Getting a lot was Siemens’ GOKnee3D software, which promised to cut MR knee exams (usually 20 minutes) in about half. Other Siemens WIPs generated buzz, namely the company’s latest CT scanners — Somatom go. All and go.Top — as well as Siemens’ FAST 3D Camera, a camera-software combination designed to leverage artificial intelligence algorithms to position patients on Siemens’ ultrapremium CTs. 

And Siemens was not the only one exhibiting works in progress. Other big-name WIP presenters (and their to-be products) included Philips Healthcare (Prodiva 1.5T) and Canon Group’s Toshiba (Aquilion Precision)

The status of many WIPs typically is due to FDA rules against vendors marketing technologies before clearing the agency’s 510(k) process. Devices going through this process are “substantially equivalent” to ones already on the market. (It never ceases to amaze me how many “breakthroughs” on the RSNA exhibit floor receive 510(k) clearances.)

Reviews should be done 90 days after companies submit applications. But the timelines can extend much longer. For example, reviewers might formally ask vendors questions about devices being reviewed. This can throw a monkey wrench into productization timelines. 

This is why vendors don’t usually predict when products “pending FDA clearance” will begin shipping. As one vendor emailed me (with an emoji wink and smile), the FDA “does not like it when companies predict such things.” 

But U.S. regulators are only one source of delays. GE’s new premium CT, the Revolution Frontier, has cleared the FDA. Yet, the company doesn’t plan to begin shipping the product until second quarter 2018.

Sometimes delays can be anticipated; sometimes not. Uncertainty has been around for a while.

 

A Long History Of RSNAs

More than a year after its news conference, OpenSpeed had been installed in fewer than two dozen locations (“Patients Embrace New Generation of Imaging Machines,” New York Times, May 8, 2001). Back then, I had anticipated neither the issues that kept OpenSpeed from being a breakout success nor the difficulty that Siemens would encounter developing its 1T open MR.

Today, all but one vendor has stepped away from the high-field open marketplace in favor of wide-bore scanners. But, when reporting the introduction of OpenSpeed, I wrote – incorrectly – that within the next five to 10 years “open MRI scanners will be available up to, if not beyond, 1.5 Tesla” (“GE brings high-field MRI to open scanning environments,” Diagnostic Imaging, November 1999). Thankfully, I attributed that statement to “industry visionaries.” (Stupid visionaries…)

As the most recent meeting demonstrated, works in progress continue to appear on the RSNA exhibit floor. And they will likely continue to do so for years to come.

So, when you look back at RSNA 2017 and forward to upcoming ones, remember the joke…and smile. I do.

 

Read Freiherr's overview article on RSNA 2017 "Value in Radiology Takes on Added Depth at RSNA 2017."

Key RSNA 2017 Study Presentations, Trends and Video

See what vendors displayed at RSNA 2017 in listings by modality at on the ITN FastPass microsite at www.rsnafastpass.com

Related Content

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2  The first of three clinical scenarios presented to the panel with final recommendations. Mild features refer to absence of significant pulmonary dysfunction or damage. Pre-test probability is based upon background prevalence of disease and may be further modified by individual’s exposure risk. The absence of resource constraints corresponds to sufficient availability of personnel, personal protective equipment, COVID-19 testing, hospital beds, and/or ve

 The first of three clinical scenarios presented to the panel with final recommendations. Mild features refer to absence of significant pulmonary dysfunction or damage. Pre-test probability is based upon background prevalence of disease and may be further modified by individual’s exposure risk. The absence of resource constraints corresponds to sufficient availability of personnel, personal protective equipment, COVID-19 testing, hospital beds, and/or ventilators with the need to rapidly triage patients. Contextual detail and considerations for imaging with CXR (chest radiography) versus CT (computed tomography) are presented in the text. (Pos=positive, Neg=negative, Mod=moderate). [Although not covered by this scenario and not shown in the figure, in the presence of significant resources constraints, there is no role for imaging of patients with mild features of COVID-19.] Image courtesy of the journal Radiology

News | Coronavirus (COVID-19) | April 07, 2020
April 7, 2020 — A multinational consens...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Chest CT findings of pediatric patients with COVID-19 on transaxial images. (a) Male, 2 months old, 2 days after symptom onset. Patchy ground-glass opacities GGO in the right lower lobe

Chest CT findings of pediatric patients with COVID-19 on transaxial images. Male, 2 months old, 2 days after symptom onset. Patchy ground-glass opacities GGO in the right lower lobe. Image courtesy of Radiology: Cardiothoracic Imaging

News | Coronavirus (COVID-19) | April 06, 2020
April 6, 2020 — Children and teenagers with COVID-19...
An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal.

An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. Photo by Dave Fornell

Feature | Radiology Imaging | April 02, 2020 | By Katie Caron
A new year — and decade — offers the opportunity to reflect on the advancements and challenges of years gone by and p
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 A brief article from Henry Ford Health System in Detroit, published today in Radiology, reports on the first presumptive case of COVID-19–associated acute necrotizing hemorrhagic encephalopathy.

A, Image from noncontrast head CT demonstrates symmetric hypoattenuation within the bilateral medial thalami (arrows). B, Axial CT venogram demonstrates patency of the cerebral venous vasculature, including the internal cerebral veins (arrows). C, Coronal reformat of aCT angiogram demonstrates normal appearance of the basilar artery and proximal posterior cerebral arteries. Image courtesy of the Radiological Society of North America (RSNA)

News | Coronavirus (COVID-19) | March 31, 2020
March 31, 2020 — A brief article fr
RSNA's open data repository will compile images and correlative data to create a comprehensive source for COVID-19 research and education efforts #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Coronavirus (COVID-19) | March 30, 2020
March 30, 2020 — The medical imaging community around the world is uniting to help address the...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Typical CT imaging features for COVID-19. Unenhanced, thin-section axial images of the lungs in a 52-year-old man with a positive RT-PCR (A-D) show bilateral, multifocal rounded (asterisks) and peripheral GGO (arrows) with superimposed interlobular septal thickening and visible intralobular lines (“crazy-paving”). Routine screening CT for diagnosis or exclusion of COVID-19 is currently not recommended by most professional organizations or the US Centers for Disease Control and Prevention. Image courtesy of RSNA

News | Coronavirus (COVID-19) | March 26, 2020
March 26, 2020 — The Radiological Society of North America (RSNA
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Representative examples of the attention heatmaps generated using Grad-CAM method for (a) COVID-19, (b) CAP, and (c) Non-Pneumonia. The heatmaps are standard Jet colormap and overlapped on the original image, the red color highlights the activation region associated with the predicted class. COVID-19 = coronavirus disease 2019, CAP = community acquired pneumonia. Image courtesy of the journal Radiology

News | Coronavirus (COVID-19) | March 20, 2020
March 20, 2020 — An arti...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Series CT scans in 35-year-old woman with COVID-19 pneumonia. (a) Scan obtained on illness days 1 showed multiple pure ground-glass opacity (GGO) mainly in right lower lobe. (b) Scan obtained on illness days 5 showed increased extent of GGO and early consolidation. (c) Scan obtained on illness days 11 showed multiple consolidation with almost the same extent. (d) Scan obtained on illness days 15 showed a mixed pattern with a slightly smaller extent, and the perilobular consolidation might suggest the presence of organizing pneumonia. The patient was discharged on illness days 17. Image courtesy of the journal Radiology

News | Coronavirus (COVID-19) | March 20, 2020
March 20, 2020 — In a new study pub
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SBI20

Image courtesy of Getty Images

News | Coronavirus (COVID-19) | March 17, 2020
March 17, 2020 — The journal Radiology ...